Technical Analysis for LAB - Standard BioTools Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.60 | -1.23% | -0.02 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Inside Day | Range Contraction | -1.23% | |
| Wide Bands | Range Expansion | -1.23% | |
| Up 3 Days in a Row | Strength | -1.23% | |
| Oversold Stochastic | Weakness | -1.23% | |
| Slingshot Bearish | Bearish Swing Setup | -0.62% | |
| Wide Bands | Range Expansion | -0.62% | |
| Oversold Stochastic | Weakness | -0.62% |
| Alert | Time |
|---|---|
| Up 3% | 1 day ago |
| Possible NR7 | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
| Up 2% | 1 day ago |
Get a Trading Sidekick!
- Earnings date: 10/30/2024
Standard BioTools Inc. Description
Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Disease Natural Sciences Immunotherapy Medical Research Flow Cytometry
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.04 |
| 52 Week Low | 1.21 |
| Average Volume | 1,894,331 |
| 200-Day Moving Average | 2.19 |
| 50-Day Moving Average | 1.87 |
| 20-Day Moving Average | 1.87 |
| 10-Day Moving Average | 1.72 |
| Average True Range | 0.14 |
| RSI (14) | 38.65 |
| ADX | 25.61 |
| +DI | 20.87 |
| -DI | 27.51 |
| Chandelier Exit (Long, 3 ATRs) | 1.90 |
| Chandelier Exit (Short, 3 ATRs) | 1.88 |
| Upper Bollinger Bands | 2.37 |
| Lower Bollinger Band | 1.37 |
| Percent B (%b) | 0.23 |
| BandWidth | 53.55 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0478 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.74 | ||||
| Resistance 3 (R3) | 1.75 | 1.71 | 1.72 | ||
| Resistance 2 (R2) | 1.71 | 1.67 | 1.71 | 1.71 | |
| Resistance 1 (R1) | 1.66 | 1.65 | 1.64 | 1.65 | 1.70 |
| Pivot Point | 1.62 | 1.62 | 1.61 | 1.61 | 1.62 |
| Support 1 (S1) | 1.56 | 1.58 | 1.54 | 1.55 | 1.50 |
| Support 2 (S2) | 1.52 | 1.56 | 1.52 | 1.49 | |
| Support 3 (S3) | 1.47 | 1.52 | 1.48 | ||
| Support 4 (S4) | 1.46 |
